Everest Clinical Research Announces Key Leadership Appointments to Drive Continued Growth

TORONTO  – February 13, 2025 – Everest Clinical Research Corporation (Everest), a global full-service Contract Research Organization (CRO), announces the promotion of Jin Dai from her current position of Chief Operating Officer (COO) to the position of Chief Executive Officer (CEO). At the same time, the company appoints Rob Woolson as its new Chief Operating Officer…

Read More

Everest Announces Acquisition of August Research

TORONTO —November 7, 2023—Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in clinical data management, biostatistics and statistical programming, today announced it has acquired August Research (“August”). Everest is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, D.C. based private equity firm with extensive experience investing in…

Read More

Everest Announces Acquisition of Brightech International

TORONTO – December 1, 2022 – Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (“Brightech”). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to…

Read More

Access clinical trial data visualizations through our Clinical Data Dashboard

By integrating data across disparate systems, insights into trial operations, data integrity and patient information are centralized at your finger tips. Everest has leveraged its strong foundation in data and analytics to provide clinical data dashboard solutions to our clients. The Dashboard initiative brings together data across clinical trial systems – which includes EDC, IWRS/IRT,…

Read More